目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Biosimilars, by Type, Through 2025
Figure Summary : Global Market for Biosimilars, by Type, 2018-2025

Chapter- 3: Market and Technology Background
Terminology of Biosimilars
Definitions of Biosimilars
Development of a Biosimilar
Biosimilars Versus Biobetters
Popular Types of Biosimilars
Table 1 : Differences between Generic and Biosimilar Drugs

Chapter- 4: Market Breakdown by Type of Biosimilar
Global Market for Biosimilars by Type
Table 17 : Number of Approved Biosimilars, by Reference Product, February 2021

Chapter- 5: Market Breakdown by Therapeutic Application
Global Market for Therapeutic Applications of Biosimilars

Chapter- 6: Market Breakdown by Region
Introduction
Global Trends
Market by Geographical Region
Recombinant Hormone Biosimilars
Recombinant Growth Factor Biosimilars
Monoclonal Antibody Biosimilars
Fusion Protein Biosimilars
Interferon Biosimilars
Low Molecular Weight Heparin (Enoxaparin Sodium) Biosimilars

Chapter- 7: Industry Structure
Types of Market Players
Emerging Trends in the Biosimilar Industry
Leading Manufacturers/Suppliers of Biosimilar Drugs

Chapter- 8: Regulatory Aspects
Biosimilar Regulations in Europe
Biosimilar Regulations in the U.S.
Biosimilar Regulations in Emerging Markets
Naming of Biosimilars
Interchangeability and Substitution

Chapter- 9: Patent Analysis
Patent Regulations in Favor of Branded Biologics
Patent Regulations in Favor of Biosimilars
Patent Activity in Biosimilars, 2018 Through February 2021

Chapter- 10: Clinical Trials
Biosimilars in Clinical Trials
Clinical Trials Analysis

Chapter- 11: Analysis of Market Forces
Market Dynamics
Figure 64 : SWOT Analysis of the Market for Biosimilars

Chapter- 12: Company Profiles
3S BIO INC.
ALVOTECH
AMGEN INC.
BIOCAD
BIOCON LTD.
BIOEQ GMBH
BIOPARTNERS GMBH
BIOSIDUS S.A.
BIO-THERA SOLUTIONS LTD.
BIOXPRESS THERAPEUTICS S.A.
BLAU FARMACEUTICA S/A
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
CHONG KUN DANG PHARMACEUTICAL CORP.
CELLTRION INC.
CIPLA LTD.
CINNAGEN
COHERUS BIOSCIENCES INC.
DM BIO LTD.
DONG-A SOCIO HOLDINGS
DR. REDDY'S LABORATORIES LTD.
EMCURE PHARMACEUTICALS LTD.
FRESENIUS KABI AG
FORMYCON AG
GEDEON RICHTER PLC
GENESCIENCE PHARMACEUTICALS CO., LTD.
GC PHARMA (FORMERLY GRESS CROSS CORP.)
HANGZHOU JIUYUAN GENE ENGINEERING CO., LTD.
HANWHA CHEMICAL CORP.
HARVEST MOON PHARMACEUTICALS U.S.A. INC.
INNOVENT BIOLOGICS CO., LTD.
INTAS PHARMACEUTICALS LTD.
JHL BIOTECH INC.
JCR PHARMACEUTICALS CO., LTD.
KISSEI PHARMACEUTICAL CO., LTD.
LG CHEM (FORMERLY LG LIFE SCIENCES)
LUPIN LTD.
MABXIENCE S.A.
MYLAN N.V. (NOW VIATRIS INC.)
NANOGEN BIOPHARMACEUTICAL CO.
NEUCLONE
NIPPON KAYAKU CO., LTD.
PFENEX INC.
PFIZER INC.
PHARMAPARK LLC
PRESTIGE BIOPHARMA PTE LTD.
PROBIOMED S.A.
RELIANCE LIFE SCIENCES
SAMSUNG BIOEPIS CO., LTD.
SANDOZ INTERNATIONAL GMBH
SHANGHAI HENLIUS BIOTECH INC.
STADA ARZNEIMITTEL AG
TANVEX BIOPHARMA INC.
TEVA PHARMACEUTICALS INDUSTRIES LTD.
USV PVT. LTD.
WOCKHARDT LTD.
XIAMEN AMOYTOP BIOTECH CO., LTD.
ZYDUS CADILA

Chapter- 13: Appendix: Acronyms
Table 141 : Acronyms Used in the Market for Biosimilars